Taysha Gene Therapies Inc - ESG Rating & Company Profile powered by AI
The Disclosure rating covers seventeen UN SDGs including: 'Quality Education', 'Climate Action' and 'Life on Land'. The page contains a Q&A table on Taysha Gene Therapies Inc. The assessment of Taysha Gene Therapies Inc is prepared by All Street Sevva using proprietary machine learning.
Taysha Gene Therapies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 0.0, social score of 1.6 and governance score of 3.2.
1.6
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1682 | Viracta Therapeutics Inc | 1.7 | Low |
1682 | Werewolf Therapeutics Inc | 1.7 | Low |
1715 | Taysha Gene Therapies Inc | 1.6 | Low |
1715 | CareDx Inc | 1.6 | Low |
1715 | Catalyst Biosciences Inc | 1.6 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Taysha Gene Therapies Inc have an accelerator or VC vehicle to help deliver innovation?
Does Taysha Gene Therapies Inc disclose current and historical energy intensity?
Does Taysha Gene Therapies Inc report the average age of the workforce?
Does Taysha Gene Therapies Inc reference operational or capital allocation in relation to climate change?
Does Taysha Gene Therapies Inc disclose its ethnicity pay gap?
Does Taysha Gene Therapies Inc disclose cybersecurity risks?
Does Taysha Gene Therapies Inc offer flexible work?
Does Taysha Gene Therapies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Taysha Gene Therapies Inc disclose the number of employees in R&D functions?
Does Taysha Gene Therapies Inc conduct supply chain audits?
Does Taysha Gene Therapies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Taysha Gene Therapies Inc conduct 360 degree staff reviews?
Does Taysha Gene Therapies Inc disclose the individual responsible for D&I?
Does Taysha Gene Therapies Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Taysha Gene Therapies Inc disclose current and / or historical scope 2 emissions?
Does Taysha Gene Therapies Inc disclose water use targets?
Does Taysha Gene Therapies Inc have careers partnerships with academic institutions?
Did Taysha Gene Therapies Inc have a product recall in the last two years?
Does Taysha Gene Therapies Inc disclose incidents of discrimination?
Does Taysha Gene Therapies Inc allow for Work Councils/Collective Agreements to be formed?
Has Taysha Gene Therapies Inc issued a profit warning in the past 24 months?
Does Taysha Gene Therapies Inc disclose parental leave metrics?
Does Taysha Gene Therapies Inc disclose climate scenario or pathway analysis?
Does Taysha Gene Therapies Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Taysha Gene Therapies Inc disclose the pay ratio of women to men?
Does Taysha Gene Therapies Inc support suppliers with sustainability related research and development?
Does Taysha Gene Therapies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Taysha Gene Therapies Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Taysha Gene Therapies Inc involved in embryonic stem cell research?
Does Taysha Gene Therapies Inc disclose GHG and Air Emissions intensity?
Does Taysha Gene Therapies Inc disclose its waste policy?
Does Taysha Gene Therapies Inc report according to TCFD requirements?
Does Taysha Gene Therapies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Taysha Gene Therapies Inc disclose energy use targets?
Does Taysha Gene Therapies Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Taysha Gene Therapies Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Taysha Gene Therapies Inc
These potential risks are based on the size, segment and geographies of the company.
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-101 for the treatment of GM2 gangliosidosis; TSHA-118 for the treatment of CLN1 disease; and TSHA-102 for the treatment of Rett syndrome. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments; and collaboration with Yale University to advance mini-gene payloads for an AAV gene therapy for the treatment of neurodevelopmental disorders. The company was incorporated in 2019 and is based in Dallas, Texas.